Aktie PARABDRUGS PARABOLIC DRUGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Parabolic Drugs Limited

Aktien

PARABDRUGS

INE618H01016

PARABDRUGS

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended 31 December, 2020
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Quarter and Half Year Ended September 30, 2020
Parabolic Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended March 31, 2020
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Quarter Ended September 30, 2018
Parabolic Extends Submission Date For EOI’s
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Second Quarter and Half Year Ended September 30, 2018
Parabolic Drugs Limited Announces Unaudited Earnings Results for the Quarter Ended June 30, 2018
Parabolic Drugs Limited Announces Change of Registered/Corporate Office
Parabolic Drugs Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Year Ended March 31, 2018
Parabolic Drugs Ltd. Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017
Parabolic Drugs Limited Announces Executive Changes
Parabolic Drugs Limited Announces Executive Changes
Parabolic Drugs Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2017
Parabolic Drugs Ltd. Announces Unaudited Earnings Results for First Quarter Ended June 30, 2017
Parabolic Drugs Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Year Ended March 31, 2017
Parabolic Drugs Ltd Appoints Ashok Kumar Jindal as CFO
Parabolic Drugs Ltd. Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016
Parabolic Drugs Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2016
Parabolic Drugs Limited Announces Resignation of Sandeep Sharma as Chief Financial Officer
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. PARABDRUGS Aktie
  4. Nachrichten Parabolic Drugs Limited
  5. Andere Sprachen